Oklo Inc. (NYSE:OKLO – Get Free Report)’s stock price traded down 3.1% during trading on Friday after UBS Group lowered their price target on the stock from $95.00 to $60.00. UBS Group currently has a neutral rating on the stock. Oklo traded as low as $50.15 and last traded at $50.2210. 6,327,169 shares changed hands during trading, a decline of 39% from the average session volume of 10,454,525 shares. The stock had previously closed at $51.81.
Several other research analysts have also issued reports on the company. Craig Hallum restated a “hold” rating on shares of Oklo in a research report on Wednesday, March 18th. Wedbush reiterated an “outperform” rating on shares of Oklo in a report on Friday, January 9th. Cantor Fitzgerald reissued an “overweight” rating and set a $122.00 price target on shares of Oklo in a research note on Wednesday, March 18th. Texas Capital upgraded Oklo to a “strong-buy” rating in a report on Tuesday, January 27th. Finally, B. Riley Financial cut their price objective on Oklo from $129.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, March 18th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Oklo presently has a consensus rating of “Moderate Buy” and an average target price of $84.30.
View Our Latest Analysis on Oklo
Insider Buying and Selling at Oklo
Oklo News Summary
Here are the key news stories impacting Oklo this week:
- Positive Sentiment: Regulatory progress for the Aurora reactor program was reported, suggesting advancement on licensing milestones that de‑risk the company’s flagship project and its timeline to commercial revenue. Regulatory progress for Aurora
- Positive Sentiment: Oklo completed the acquisition of Atomic Alchemy to enter domestic production of medical and industrial isotopes, diversifying revenue potential beyond reactors and shortening a path to cash flow. The company also reiterated reactor progress in the same update. Oklo Acquisition And Reactor Progress Reframe Long Term Investor Debate
- Positive Sentiment: CEO and co‑founder Jacob DeWitte was appointed to the President’s Council of Advisors on Science and Technology (PCAST), a high‑profile government advisory role that can improve regulatory access and legitimacy for advanced nuclear projects. Oklo Co-Founder and CEO Appointed to Serve on President’s Council of Advisors on Science and Technology
- Neutral Sentiment: Analysts remain conflicted on Oklo alongside other utilities/energy names, reflecting divergent views on commercialization timelines and regulatory risk that increase short‑term volatility. Analysts Conflicted on These Utilities Names: Oklo Inc (OKLO) and PG&E (PCG)
- Neutral Sentiment: Comparative coverage with peers (e.g., Montauk Renewables) has appeared, useful for investors benchmarking Oklo’s valuation and business model but not a direct positive/negative catalyst. Critical Comparison: Montauk Renewables (NASDAQ:MNTK) and Oklo (NYSE:OKLO)
- Negative Sentiment: UBS cut its price target from $95 to $60 and set a “neutral” rating, signaling lower near‑term upside and contributing to selling pressure. Benzinga
- Negative Sentiment: B. Riley trimmed its price target to $92, another downward analyst revision that likely dampened sentiment despite longer‑term growth narratives. OKLO Price Target Trimmed to $92
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the company. NBC Securities Inc. lifted its holdings in shares of Oklo by 75.0% in the 4th quarter. NBC Securities Inc. now owns 350 shares of the company’s stock worth $25,000 after buying an additional 150 shares during the period. GAMMA Investing LLC grew its position in shares of Oklo by 356.3% during the 4th quarter. GAMMA Investing LLC now owns 365 shares of the company’s stock worth $26,000 after buying an additional 285 shares in the last quarter. Armstrong Advisory Group Inc. purchased a new position in shares of Oklo during the third quarter valued at $27,000. Elevation Point Wealth Partners LLC purchased a new position in shares of Oklo during the second quarter valued at $28,000. Finally, Gables Capital Management Inc. bought a new stake in shares of Oklo in the third quarter valued at about $28,000. 85.03% of the stock is currently owned by hedge funds and other institutional investors.
Oklo Price Performance
The firm has a fifty day moving average of $68.12 and a two-hundred day moving average of $93.99. The stock has a market capitalization of $8.72 billion, a P/E ratio of -69.75 and a beta of 0.80.
Oklo (NYSE:OKLO – Get Free Report) last issued its earnings results on Tuesday, March 17th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.10). During the same period in the prior year, the company posted ($0.74) EPS. As a group, sell-side analysts forecast that Oklo Inc. will post -8.2 EPS for the current fiscal year.
Oklo Company Profile
Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.
The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.
Recommended Stories
Receive News & Ratings for Oklo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oklo and related companies with MarketBeat.com's FREE daily email newsletter.
